Patients with rheumatoid arthritis are at an increased risk of developing cardiovascular disease. Researchers at Mayo Clinic have now developed a simple approach to predict the risk of cardiovascular events within ten years of diagnosis of rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Researchers may be able to predict whether preeclampsia will occur in pregnant women who have SLE, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
The use of combination TNF-inhibitor-methotrexate therapy in people with rheumatoid arthritis was associated with a risk of heart attack that was reduced by 80 percent in comparison with those using methotrexate alone, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
In early inflammatory arthritis, higher rates of remission are achieved if treatment is started early with conventional therapies and patients are more closely followed, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
A potential new therapy called certolizumab pegol, when used in combination with methotrexate, may be safe and effective at treating active rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
Being overweight can prevent sufferers of rheumatoid arthritis from going into remission, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Phase III testing shows that a potential new therapy called tocilizumab is safe and effective in the treatment of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Denosumab treatment every six months can reduce bone erosions in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
On Wednesday, September 19, the American College of Rheumatology and the Arthritis Foundation will jointly brief members of Congress and their staffs about the devastating effects of arthritis and related rheumatic diseases. During the briefing, both organizations will request Congressional support of the "Arthritis Prevention, Control and Cure Act of 2007" (S.626/H.R. 1283).
The American College of Rheumatology Research and Education Foundation (ACR REF) has selected 15 experienced researchers from leading institutions to receive an estimated $6 million from the Foundation's new "Within Our Reach: Finding a Cure for Rheumatoid Arthritis" campaign.
The American College of Rheumatology Research and Education Foundation (REF) today announced that Amgen Inc. and Wyeth Pharmaceuticals have committed more than $5.5 million to support programs designed by the REF to ensure that a highly trained workforce is available to provide clinical care to patients with rheumatic diseases.
Association of Rheumatology Health Professionals offers audioconference on physical intimacy, sex and rheumatic disease.
A stronger quadricep, the muscle responsible for straightening the leg at the knee joint, does not lead to damage in the knee and helps prevent the deterioration of cartilage behind the knee cap among those with knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
A phase I trial of non-myeloablative or reduced intensity hematopoietic stem cell transplantation (HSCT) in patients with systemic sclerosis (scleroderma) has proven safe and well tolerated, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Women who have been diagnosed with systemic lupus erythematosus face increased risks of death, infection, clotting complications, and complications related to blood loss when they become pregnant, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Pregabalin, typically used to treat nerve pain or seizures, appears to offer extended pain relief for those with fibromyalgia, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Very attainable weight loss goals are sufficient to reduce pain and therefore motivate overweight patients with knee osteoarthritis to keep that weight off, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Can you intervene early in the progression of a disease to prevent it from becoming chronic and full-blown? Evidently yes if those patients with probable rheumatoid arthritis have anti-CCP antibodies, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
A leg length difference of as little as two centimeters (about 4/5s of an inch) is definitely associated with knee and hip osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Despite being immunosuppressed, patients with rheumatoid arthritis are able to develop protective antibodies following pneumococcal and influenza vaccinations when also treated with anti-TNF agents, thus reducing their risk for developing the flu and the most common type of bacterial pneumonia, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Early administration of methotrexate and infliximab may lead to remission in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Adalimumab, an injectable anti-TNF therapy that has FDA approval for treating rheumatoid arthritis in adults, has proven effective in children with juvenile rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
The protein marker, metalloproteinase 3, now identified as the first significant predictor of joint damage in ankylosing spondylitis, could change patient treatment approaches, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
One in four persons. It is the first lifetime risk estimate for symptomatic hip osteoarthritis, and the risks are even higher for those who are overweight or obese, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
A long-term study of over 170,000 women in the U.S. confirms that previously identified risk factors in postmenopausal women, as well as a few surprising factors, predict future fracture risk, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
WASHINGTON, DC "“ Genetic evidence now indicates that knee osteoarthritis can no longer be relegated to a strictly "wear and tear" category, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
The effectiveness of TNF inhibitor therapy in treating rheumatoid arthritis is dependent, in part, on the level of TNF in each patient's tissues, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Electro- and traditional acupuncture may reduce joint tenderness in the treatment of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Infliximab, an antibody directed against tumor necrosis factor, has been shown to produce improvement in the signs and symptoms of ankylosing spondylitis and psoriatic arthritis. In research presented this week, early changes in certain blood proteins, or biomarkers, were found to be predictive of later clinical response to the drug in these two diseases.
Data from one large U.S. registry indicate that biologic therapy does not appear to increase overall risks of cancers other than skin cancers in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
Climatic factors such as heat and humidity that lead to dehydration can signal a future attack for gout sufferers, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington DC.
Injections of intra-articular neurotoxins may offer relief from severe knee pain for osteoarthritis patients who are not candidates for joint reconstruction, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC.
For patients with pulmonary arterial hypertension occurring in association with diseases of the connective tissues, sildenafil (Revatio) can improve their ability to exercise as well as the movement of blood through their cardiac system.
Gene signatures, or patterns, can yield important information about the severity and frequency of systemic lupus erythematosus activity.
Even minimal weight loss can significantly reduce pain and stiffness, and improve day-to-day functioning for those with mild to moderate knee osteoarthritis.
The BeSt study is a multi-center, randomized controlled trial designed to evaluate the effectiveness of four different treatment strategies for patients with early, active rheumatoid arthritis who had not yet received DMARD therapy.
Higher doses of risedronate (Actonel), a drug typically utilized to combat the effects of osteoporosis in post-menopausal women, may delay joint destruction and the need for joint replacement surgery in patients with knee osteoarthritis.
At-home exercise and weight-loss intervention for the elderly can improve function lost to knee osteoarthritis.
Women with systemic lupus erythematosus and rheumatoid arthritis experience more pregnancy complications and longer hospitalizations then do women in the general obstetric population.
Whether male or female, people suffering with gout share certain risk factors.
Glucosamine and chondroitin sulfate may be an effective combination in reducing pain associated with osteoarthritis of the knee.
Rituximab, a genetically-engineered antibody, has proven to be an effective adjunct therapy for patients with rheumatoid arthritis who have not responded adequately to one or more anti-TNF inhibitors.
Rheumatoid arthritis patients are less likely to take the daily doses of aspirin recommended to reduce cardiovascular risks despite their increased risks of heart attack.
Earlier use of second-line medications may generate significant improvement in patients with juvenile rheumatoid arthritis.
European GUIDE (Glucosamine Unum In Die [once a day] Efficacy) medical investigation results indicate that glucosamine sulfate may have more ability to control pain due to knee osteoarthritis than does acetaminophen.
Rheumatoid arthritis patients are right - the seasons do affect the signs and symptoms of their disease.
Insufficient levels of selenium in the body may be associated with a higher frequency of knee osteoarthritis.
Patients who do not respond to methotrexate therapy for the treatment of rheumatoid arthritis may have another option in CNTO 148 (golimumab).
Based on a large study, the use of anti-TNF inhibitors and methotrexate may reduce mortality risks in rheumatoid arthritis patients.
Patients and physicians need to communicate more effectively about treatment management for knee pain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right